Skip to main content
Caplight Logo









Panarum Corp

Panarum Corp

Private
Newark, DelawareHealthcare & Life Scienceshttps://panarum.com

Last Round

Accelerator

Feb 18, 2025

Total Funding Raised

$640,000

Company Overview

Panarum Corp is a pharmaceutical technology company that has developed Proteoral®, a technology for the oral delivery of biologic drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

oral drug deliverydrug delivery platformoral biologicsinjectable to oral conversiondrug reformulationbiologic drug deliveryneedle-free biologicslarge-molecule deliverypharmaceutical technologyoral peptidesoral proteinsrecombinant protein excipientpharmaceutical partnershipsparacellular transport

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Panarum Corp Comparables

Compare Panarum Corp with similar companies based on industry and business-model similarity.

Panarum Corp comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cyprumed GmbH
90%
Intract Pharma
86%
Vivtex
85%

Panarum Corp Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 18, 2025
GrantNov 22, 2023
AcceleratorJul 28, 2021
SeedDec 21, 2020
AngelDec 1, 2017

Panarum Corp Investors

Notable investors and investment history

Panarum Corp investors
InvestorRounds
Johnson & Johnson FoundationAccelerator
Draper Startup HouseAccelerator
Draper UniversityAccelerator
Village CapitalAccelerator
Draper CygnusSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2021

    Funded by Draper Startup House and Draper University.

Panarum Corp Filings

Explore SEC and related filing metadata, where available.

Panarum Corp filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Panarum Corp's valuation, stock price, and market status.

Is Panarum Corp a public or private company?

Panarum Corp is a private company.

What is the current stock price of Panarum Corp?

Panarum Corp is a private company with no public stock price. No recent secondary market data is available.

How much is Panarum Corp worth (valuation)?

Valuation information for Panarum Corp is not publicly available.

Can I buy Panarum Corp stock?

Panarum Corp shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Panarum Corp's last funding round?

Funding round information for Panarum Corp is not publicly available.

Who are the main investors in Panarum Corp?

Investor information for Panarum Corp is not publicly disclosed.

Will Panarum Corp IPO soon?

No public IPO plans have been announced for Panarum Corp.

How can I track Panarum Corp secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panarum Corp's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewark, Delaware
Employee Range2
Year Founded2017
Last FundingFeb 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?